Inventor · disambiguated record
Jacques Mallet
Also filed as: MALLET JACQUES
23 granted patents·19 pending applications·413 citations·filing 1993–2023
95Inventor score
Files withAVENTIS PHARMA SA12RHONE POULENC RORER SA9CENTRE NAT RECH SCIENT3MALLET JACQUES3INST NAT SANTE RECH MED2
Top patents by PatentIndex Score
42 records- 0188US6756523B1Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brainAVENTIS PHARMA SA·Filed 1995·Granted Jun 29, 2004·96 cites·108 claims
- 0288US6632427B1Adenoviral-vector-mediated gene transfer into medullary motor neuronsAVENTIS PHARMA SA·Filed 1997·Granted Oct 14, 2003·109 cites·24 claims
- 0380US8119119B2Non-integrative and non-replicative lentivirus, preparation and uses thereofMALLET JACQUES·Filed 2005·Granted Feb 21, 2012·13 cites·12 claims
- 0479US5648259APolypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applicationsRHONE POULENC RORER SA·Filed 1993·Granted Jul 15, 1997·51 cites·16 claims
- 0575US7749973B2Methods of gene transfer to astrocytes with mokola virus pseudotyped lentivirus vectorsCENTRE NAT RECH SCIENT·Filed 2002·Granted Jul 6, 2010·7 cites·5 claims
- 0671US6210879B1Method for diagnosing schizophreniaRHONE POULENC RORER SA·Filed 1996·Granted Apr 3, 2001·57 cites·21 claims
- 0768US2023313161A1Diet controlled expression of a nucleic acid encoding cas9 nuclease and uses thereofINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0865US7241591B2Adenovirus comprising a gene coding for glutathione peroxidaseAVENTIS PHARMA SA·Filed 2004·Granted Jul 10, 2007·2 cites·4 claims
- 0964US6245330B1Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF)AVENTIS PHARMA SA·Filed 1995·Granted Jun 12, 2001·28 cites·24 claims
- 1063US7018628B1Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebratesAVENTIS PHARMA SA·Filed 1999·Granted Mar 28, 2006·19 cites·6 claims
- 1160US12419971B2Diet controlled expression of a nucleic acid encoding a pro-apoptotic proteinINSTITUT NATIONAL DE RECH POUR LAGRICULTURE LALIMENTATION ET LENVIRONNEMENT·Filed 2019·Granted Sep 23, 2025·0 cites·10 claims
- 1257US8071753B2RNAi mediated expression inhibition of a cholinergic proteinBERRARD SYLVIE·Filed 2009·Granted Dec 6, 2011·1 cites·20 claims
- 1355US6685934B1Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)AVENTIS PHARMA SA·Filed 1995·Granted Feb 3, 2004·12 cites·21 claims
- 1455US2005069523A1Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)RHONE POULENC RORER SA·Filed 2003·Application pending·0 cites
- 1553US6723315B1Method for treating amyotrophic lateral sclerosisAVENTIS PHARMA SA·Filed 1997·Granted Apr 20, 2004·12 cites·65 claims
- 1651US2005244381A1Adenovirus including a gene coding for a superoxide dismutaseAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 1750US2004009592A1Genetically-modified neural progenitors and uses thereofRHONE POULENC RORER SA·Filed 2002·Application pending·0 cites
- 1849US2010098664A1Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expressionDESCLAUX MATHIEU JEAN-FRANCOIS·Filed 2007·Application pending·0 cites
- 1948US7341718B2Neuronal gene transfer of adenovirus and herpes virus vectorsCENTRE NAT RECH SCIENT·Filed 2002·Granted Mar 11, 2008·0 cites·13 claims
- 2046US8431119B2Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseasesMALLET JACQUES·Filed 2007·Granted Apr 30, 2013·0 cites·2 claims
- 2145US7273854B1Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative disordersSANOFI AVENTIS·Filed 2000·Granted Sep 25, 2007·0 cites·4 claims
- 2243US2006121013A1Use of negative regulatory elements for the neurospecific expression of transgenesCENTELION·Filed 2005·Application pending·0 cites
- 2342US2008312171A1Tetracycline-Dependent Regulation of Rna InterferenceCENTRE NAT RECH SCIENT·Filed 2006·Application pending·0 cites
- 2442US2019185832A1Diet controlled expression of a nucleic acid encoding cas9 nuclease and uses thereofINST NAT SANTE RECH MED·Filed 2017·Application pending·0 cites
- 2539US2003219418A1Method of producing human beta cell linesFiled 2002·Application pending·0 cites
- 2638US6552003B2Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTFAVENTIS PHARMA SA·Filed 1999·Granted Apr 22, 2003·4 cites·45 claims
- 2738US2004014062A1Compositions and methods for nucleic acid or polypeptide analysesFiled 2001·Application pending·0 cites
- 2838US2003162306A1Compositions and methods for genetic analysesFiled 2001·Application pending·0 cites
- 2937US2003059809A1Biochips,preparation and usesFiled 2000·Application pending·0 cites
- 3034US2006051331A1Optimization of transgene expression in mammalian cellsMALLET JACQUES·Filed 2003·Application pending·0 cites
- 3133US6998474B1Polypeptides of the “basic helix-loop-helix” bHLH family, corresponding nucleic acid sequencesCENTELION SAS·Filed 2000·Granted Feb 14, 2006·0 cites·17 claims
- 3231US6458529B1Assays for promoter operability in central nervous system cellsAVENTIS PHARMA SA·Filed 1995·Granted Oct 1, 2002·1 cites·5 claims
- 3330US6943016B1Human adult astrocytes, their preparation and uses thereofAVENTIS PHARMA SA·Filed 2000·Granted Sep 13, 2005·0 cites·10 claims
- 3429US6140112APharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseasesRHONE POULENC RORER SA·Filed 1994·Granted Oct 31, 2000·0 cites·4 claims
- 3529US2013210739A1Bhlh proteins and their use as drugsHUGNOT JEAN-PHILIPPE·Filed 2011·Application pending·0 cites
- 3629US2003059455A1Adenovirus including a gene coding for a superoxide dismutaseRHONE POULENC RORER SA·Filed 1995·Application pending·0 cites
- 3728US2002031493A1Recombinant adenoviruses coding for glial-derived cell neurotrophic factor (gdnf)RHONE POULENC RORER SA·Filed 1997·Application pending·0 cites
- 3828US2001029249A1Adenovirus comprising a gene coding for glutathione peroxidaseFiled 1995·Application pending·0 cites
- 3927US6235497B1Recombinant expression of the rat vesicular acetylcholine transporterRHONE POULENC RORER SA·Filed 1995·Granted May 22, 2001·1 cites·6 claims
- 4025US2002006660A1Genetically-modified neural progenitors and uses thereofRHONE POULENC RORER SA·Filed 1997·Application pending·0 cites
- 4122US2002028212A1Recombinant viruses coding for a glutamate decarboxylase (gad) activityFiled 1995·Application pending·0 cites
- 4221US6432701B1Derived tyrosine hydroxylase gene expression systemAVENTIS PHARMA SA·Filed 1997·Granted Aug 13, 2002·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Jacques Mallet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →